$105.10
-6.01-5.41%
Last update: Oct 16, 4:00 PM
ProShares Ultra Nasdaq Biotechnology (BIB) Stock Price, Quote, News & History
BIBNASDAQ
You can purchase shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) through any online brokerage.
There are no as such competitors for ProShares Ultra Nasdaq Biotechnology.
There is no analysis for ProShares Ultra Nasdaq Biotechnology to provide a consensus price target.
The stock price for ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB) is $105.1016 last updated October 16, 2026 at 4:00 PM EDT.
There are no upcoming dividends for ProShares Ultra Nasdaq Biotechnology.
ProShares Ultra Nasdaq Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for ProShares Ultra Nasdaq Biotechnology.
| Sector | Healthcare |
| Category | Mid Performer-Low Growth |
| Investment Style | Trading-Leveraged Equity |
| Fund Inception | Apr 6, 2010 |
| Managers | Tarak Dave Michael Neches |
| Definition | Majority of stocks in this equity fund have average financial performance and low growth potential |
Benzinga Rankings give you vital metrics on any stock – anytime.
